DE3048700C2 - Pharmazeutische Zubereitung zur Verbesserung des Lipidstoffwechsels - Google Patents

Pharmazeutische Zubereitung zur Verbesserung des Lipidstoffwechsels

Info

Publication number
DE3048700C2
DE3048700C2 DE3048700A DE3048700A DE3048700C2 DE 3048700 C2 DE3048700 C2 DE 3048700C2 DE 3048700 A DE3048700 A DE 3048700A DE 3048700 A DE3048700 A DE 3048700A DE 3048700 C2 DE3048700 C2 DE 3048700C2
Authority
DE
Germany
Prior art keywords
iodine
eggs
feed
blood
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3048700A
Other languages
German (de)
English (en)
Other versions
DE3048700A1 (de
Inventor
Shinichirou Ibaragi Katamine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Nosan Kogyo Co Ltd
Original Assignee
Nihon Nosan Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP360780A external-priority patent/JPS56102789A/ja
Priority claimed from JP2800480A external-priority patent/JPS56125314A/ja
Application filed by Nihon Nosan Kogyo Co Ltd filed Critical Nihon Nosan Kogyo Co Ltd
Publication of DE3048700A1 publication Critical patent/DE3048700A1/de
Application granted granted Critical
Publication of DE3048700C2 publication Critical patent/DE3048700C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L15/00—Egg products; Preparation or treatment thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3048700A 1980-01-18 1980-12-23 Pharmazeutische Zubereitung zur Verbesserung des Lipidstoffwechsels Expired DE3048700C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP360780A JPS56102789A (en) 1980-01-18 1980-01-18 Composition increasing lipoprotein lipase activity, having saving action of glycogen consumption
JP2800480A JPS56125314A (en) 1980-03-07 1980-03-07 Composition for improving constitutional ratio of lipoprotein with high specific gravity in blood

Publications (2)

Publication Number Publication Date
DE3048700A1 DE3048700A1 (de) 1981-09-10
DE3048700C2 true DE3048700C2 (de) 1987-02-26

Family

ID=26337235

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3048700A Expired DE3048700C2 (de) 1980-01-18 1980-12-23 Pharmazeutische Zubereitung zur Verbesserung des Lipidstoffwechsels

Country Status (3)

Country Link
CA (1) CA1158983A (https=)
DE (1) DE3048700C2 (https=)
GR (1) GR82331B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779633B2 (ja) * 1987-01-07 1995-08-30 旭化成工業株式会社 食肉用家禽の飼育方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1692489C3 (de) * 1966-10-01 1979-03-15 Sieverding, Louis, Monterey Park, Calif. (V.St.A.) Trinke für Hühner

Also Published As

Publication number Publication date
GR82331B (https=) 1984-12-13
CA1158983A (en) 1983-12-20
DE3048700A1 (de) 1981-09-10

Similar Documents

Publication Publication Date Title
DE69012268T2 (de) Mittel zur Hemmung der alpha-Amylase Aktivität.
DE69629273T2 (de) Zusammensetzungen enthaltend Propionyl-L-Carnitine und Hydroxyzitronensäure oder Pantothensäure
EP0575846B1 (de) Lipasehemmer enthaltende Nahrungsmittel und Futtermittel
DE3338995C2 (https=)
CH653891A5 (de) Mittel fuer die orale verabreichung an einen menschen und/oder ein saeugetier.
DE69624699T2 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE69907606T2 (de) Zusammensetzung, die Panax pseudo ginseng und Eucommiae ulmoides enthält
DE3137125C2 (https=)
DE3040780C2 (de) Verwendung einer pharmazeutischen Zusammensetzung zur Behandlung von Diabetes
CH666188A5 (de) Immuno-regulator in form einer pharmazeutischen zusammensetzung.
DE60038174T2 (de) Nahrungszusammensetzung zur regulierung des körpergewichts
DE3319282C2 (https=)
DE4011285A1 (de) Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose
DE69131553T2 (de) Arzneimittel enthaltend Mischungen von höheren primären aliphatischen Alkoholen zur Behandlung von Hypercholesterolämie und Hyperlipoproteinämie Typ II und zur Stimulation des sexuellen Verhaltens bei Tieren und Menschen
DE2660486C2 (de) Verwendung von 2-Hydroxymethyl-3,4,5-trihydroxypiperidin als Arzneimittel
DE3048700C2 (de) Pharmazeutische Zubereitung zur Verbesserung des Lipidstoffwechsels
DE69230590T2 (de) Mittel gegen fettleibigkeit
DE2126533A1 (de) Verfahren zur Herstellung pharma zeutischer Zubereitungen
DE2335216A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE19815411A1 (de) Thermogenese stimulierend wirksame Arzneimittel
DE3315607A1 (de) Verwendung von albendazol in oraler verabreichungsform bei der bekaempfung von echinokokkose des menschen und arzneimittel
DE3153623C2 (https=)
DE2919291A1 (de) Die verwendung von silikagel zur senkung des fettspiegels im blut
EP0820771A2 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
DE1617508C3 (de) Antidepressive Mittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: LIEDL, G., DIPL.-PHYS. NOETH, H., DIPL.-PHYS., PAT

8161 Application of addition to:

Ref document number: 3040780

Country of ref document: DE

Format of ref document f/p: P

8162 Independent application
8128 New person/name/address of the agent

Representative=s name: LIEDL, G., DIPL.-PHYS., PAT.-ANW., 8000 MUENCHEN

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: HANSMANN, VOGESER & PARTNER, 81369 MUENCHEN

8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee